BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30209547)

  • 1. Extracellular vesicles in cancer immune responses: roles of purinergic receptors.
    Graner MW
    Semin Immunopathol; 2018 Sep; 40(5):465-475. PubMed ID: 30209547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells.
    Lindenbergh MFS; Stoorvogel W
    Annu Rev Immunol; 2018 Apr; 36():435-459. PubMed ID: 29400984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between purinergic signalling and extracellular vesicles in health and disease.
    Carotti V; Rigalli JP; van Asbeck-van der Wijst J; Hoenderop JGJ
    Biochem Pharmacol; 2022 Sep; 203():115192. PubMed ID: 35905971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenine-Based Purines and Related Metabolizing Enzymes: Evidence for Their Impact on Tumor Extracellular Vesicle Activities.
    Di Iorio P; Ciccarelli R
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer.
    Ciardiello C; Cavallini L; Spinelli C; Yang J; Reis-Sobreiro M; de Candia P; Minciacchi VR; Di Vizio D
    Int J Mol Sci; 2016 Feb; 17(2):175. PubMed ID: 26861306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic enzymes on extracellular vesicles: immune modulation on the go.
    Winzer R; Nguyen DH; Schoppmeier F; Cortesi F; Gagliani N; Tolosa E
    Front Immunol; 2024; 15():1362996. PubMed ID: 38426088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
    Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
    J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purinergic Signaling Within the Tumor Microenvironment.
    Draganov D; Lee PP
    Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular purines, purinergic receptors and tumor growth.
    Di Virgilio F; Adinolfi E
    Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
    Dubyak GR; el-Moatassim C
    Am J Physiol; 1993 Sep; 265(3 Pt 1):C577-606. PubMed ID: 8214015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptotic Tumor Cell-Derived Extracellular Vesicles as Important Regulators of the Onco-Regenerative Niche.
    Gregory CD; Dransfield I
    Front Immunol; 2018; 9():1111. PubMed ID: 29875772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic Signaling in the Hallmarks of Cancer.
    Campos-Contreras ADR; Díaz-Muñoz M; Vázquez-Cuevas FG
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How cancer cells dictate their microenvironment: present roles of extracellular vesicles.
    Naito Y; Yoshioka Y; Yamamoto Y; Ochiya T
    Cell Mol Life Sci; 2017 Feb; 74(4):697-713. PubMed ID: 27582126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Yin and Yang of tumour-derived extracellular vesicles in tumour immunity.
    Yamauchi T; Moroishi T
    J Biochem; 2021 Mar; 169(2):155-161. PubMed ID: 33226400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer.
    Yin Z; Fan J; Xu J; Wu F; Li Y; Zhou M; Liao T; Duan L; Wang S; Geng W; Jin Y
    Front Immunol; 2020; 11():2024. PubMed ID: 32983146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles in immunomodulation and tumor progression.
    Marar C; Starich B; Wirtz D
    Nat Immunol; 2021 May; 22(5):560-570. PubMed ID: 33753940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy.
    Wu F; Xie M; Hun M; She Z; Li C; Luo S; Chen X; Wan W; Wen C; Tian J
    Front Immunol; 2021; 12():658698. PubMed ID: 34093547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Vesicles and DAMPs in Cancer: A Mini-Review.
    Abu N; Rus Bakarurraini NAA; Nasir SN
    Front Immunol; 2021; 12():740548. PubMed ID: 34721407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
    Yan W; Jiang S
    Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.